Podcasts about Federal

Federal immigration crackdowns and fraud investigations in deep blue states like Minnesota and California have sparked protests, some turning violent. The Trump administration claims many demonstrations are not organic but orchestrated and funded by “dark money” groups. In this episode, we examine the funding trail with Seamus Bruner of the Government Accountability Institute. Get the facts first with Morning Wire.- - -Ep. 2644- - -Wake up with new Morning Wire merch: https://bit.ly/4lIubt3- - -Today's Sponsors:Boll & Branch - Get 15% off your first order + free shipping at https://BollAndBranch.com/wire with code wire.Hello Fresh - Go to https://HelloFresh.com/morningwire10fm to Get 10 free meals + a FREE Zwilling Knife (a $144.99 value) on your third box. Offer valid while supplies last.- - -Privacy Policy: https://www.dailywire.com/privacymorning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

The National Security Hour with LTC Sargis Sangari – A stadium is not a charity. It is private capital and local jobs. If policy chases headline projects for political reasons while choking everyday taxpayers, that signals weakness. Federal funding can be pulled when states fail basic compliance. That can cost billions in transit, childcare, and infrastructure. Credit agencies warn that thin margins and...

In 2016, French modeling agent Jean-Luc Brunel was reportedly close to cooperating with U.S. prosecutors against Jeffrey Epstein, offering to testify about how he recruited girls for Epstein's sex-trafficking operations and possessed incriminating material in exchange for immunity. Federal records show Brunel had discussions with lawyers for Epstein's victims and was planning a meeting with the U.S. Attorney's Office—suggesting he was prepared to provide evidence that could have significantly strengthened the case against Epstein years earlier. But once Epstein learned of these negotiations, Brunel suddenly went silent and ultimately never offered testimony, and prosecutors didn't take immediate action at the time.Brunel, who ran the modeling agency MC2 with Epstein's financial backing and has long been accused of facilitating abuse by recruiting vulnerable women and girls under the pretense of modeling work, was not pursued by prosecutors in 2016 and Epstein remained free until his 2019 arrest. U.S. files show that this missed cooperation set back efforts to hold Epstein accountable and allowed his exploitation to continue. Brunel was later arrested in France in 2020 on sex-crime allegations and died in custody in 2022, but the earlier opportunity to challenge Epstein's operations appears to have been lost when Brunel backed out of his planned cooperation.to contact me:bobbycapucci@protonmail.comsource:The accomplice who was going to testify against Jeffrey Epstein—then went dark

In 2016, French modeling agent Jean-Luc Brunel was reportedly close to cooperating with U.S. prosecutors against Jeffrey Epstein, offering to testify about how he recruited girls for Epstein's sex-trafficking operations and possessed incriminating material in exchange for immunity. Federal records show Brunel had discussions with lawyers for Epstein's victims and was planning a meeting with the U.S. Attorney's Office—suggesting he was prepared to provide evidence that could have significantly strengthened the case against Epstein years earlier. But once Epstein learned of these negotiations, Brunel suddenly went silent and ultimately never offered testimony, and prosecutors didn't take immediate action at the time.Brunel, who ran the modeling agency MC2 with Epstein's financial backing and has long been accused of facilitating abuse by recruiting vulnerable women and girls under the pretense of modeling work, was not pursued by prosecutors in 2016 and Epstein remained free until his 2019 arrest. U.S. files show that this missed cooperation set back efforts to hold Epstein accountable and allowed his exploitation to continue. Brunel was later arrested in France in 2020 on sex-crime allegations and died in custody in 2022, but the earlier opportunity to challenge Epstein's operations appears to have been lost when Brunel backed out of his planned cooperation.to contact me:bobbycapucci@protonmail.comsource:The accomplice who was going to testify against Jeffrey Epstein—then went dark

OA1237 - The U.S. Department of Justice is not sending their best these days. From the problematic indictments of journalists Don Lemon and Georgia Fort for their coverage of the protest of a church in Minnesota whose pastor runs the local ICE field office to the unexpected dismissal of Mohsen Mohdawi's deportation proceedings to a bizarre argument (and more good news) in Kilmar Abrego Garcia's custody proceedings, we are continuing to see what happens when authoritarian lawyering meets actual federal judges applying actual federal law to the facts and parties before them.  Finally, in today's footnote: can you sue your ex for telling millions of people about your enormous penis? We debate whether a former football player's claims are giving BDE or legal shrinkage. Federal indictment of Nakima Levy Armstrong, Don Lemon, Georgia Fort, et al in connection with January 18, 2026 protest at Cities Church DOJ Office of Civil Rights memo re: FACE Act charging policy (Jan 24, 2025) The Freedom of Access to Clinic Entrances (“FACE”) Act, 18 USC 248 Petitioner's 28(j) letter in Mahdawi v. Trump with copy of the Immigration Judge's order terminating Mohsen Mahdawi's removal proceedings attached (Feb. 17, 2026) Judge Xinis's order preventing Kilmar Abrego Garcia's re-detention by ICE (Feb. 17, 2026) Complaint in Kalil v. Kalil, filed Jan. 6, 2026 Excerpts from Rev. Jesse Jackson's “Keep Hope Alive” speech at the 1988 Democratic National Convention Check out the OA Linktree for all the places to go and things to do!

Federal health officials reduced the number of vaccines recommended for all children and reorganized the schedule to align more closely with other developed nations, giving parents clearer decision points The updated framework separates vaccines into universal, high-risk, and shared clinical decision-making categories, increasing your role in evaluating what fits your child's specific situation The U.S. moved away from being a global outlier in the number of childhood vaccines recommended for all children, signaling a shift toward a more focused national approach Officials committed to stronger research standards, including placebo-controlled trials and longer-term safety monitoring, signaling a push for more transparent evidence The revised structure encourages you to weigh risks and benefits more carefully while strengthening your child's immune resilience through foundational health habits

Share your good news with us.

Trump jokes about aliens — then orders declassification. Iran gets 15 days. DHS offices are attacked. And Democrats implode in a Texas Senate race scandal. Tara breaks down a news cycle that feels like a fever dream — but isn't.

Federal prosecutors have claimed a Venezuelan gang is entrenched in Colorado. Case filings reveal otherwise. Then, a week of whirlwind weather makes way for the return of warmer and drier days ahead. Plus, meet Colorado's new home-grown state supreme court justice, Susan Blanco. And the Local 303 celebrates Black History Month across musical genres. 

Winter storm warnings continue across northern Minnesota through Thursday morning with blizzard warnings for Duluth and the North Shore. Winds have been gusting to more than 60 mph at the Duluth airport and utilities are reporting thousands of homes and businesses without power. There's even been some lightning amid the heavy snow.To the south, rain will change over to snow Wednesday. The Twin Cities may get an inch or two by Thursday, with 2 to 4 inches for Willmar and St. Cloud.

Convidado: Octavio Guedes, comentarista da GloboNews e colunista do g1 A ordem partiu do gabinete do ministro Alexandre de Moraes. E, na terça-feira (17), agentes da Polícia Federal cumpriram mandados de busca e apreensão contra quatro servidores públicos que atuavam na Receita Federal. A ação investiga se eles acessaram e vazaram dados sigilosos de diversas autoridades, incluindo os integrantes do Supremo Tribunal Federal e seus familiares. Os servidores foram afastados de seus cargos, passaram a usar tornozeleira eletrônica e tiveram os passaportes apreendidos. A Receita Federal informou que seus sistemas são rastreáveis e que uma auditoria interna identificou irregularidades, que foram comunicadas ao STF. A investigação sobre esses possíveis vazamentos foi aberta dentro do Inquérito das Fake News, criado em 2019 e que tem Moraes como relator. Para explicar o alcance da operação da PF e as evidências sobre o vazamento dos dados sigilosos, Natuza Nery conversa com Octavio Guedes, comentarista da GloboNews e colunista do g1. Guedes analisa também as críticas direcionadas à abertura da investigação pelo Supremo e como a decisão de Moraes repercutiu dentro da Corte.

Federal government agencies have repeatedly invoked white nationalist language and images in the year since President Trump returned to the White House for his second term. We discuss the intended target of those messages and what effects they have. This episode: senior White House correspondent Tamara Keith, domestic extremism correspondent Odette Yousef, and senior national political correspondent Mara Liasson.This podcast was produced by Casey Morell and Bria Suggs, and edited by Rachel Baye.Our executive producer is Muthoni Muturi.Listen to every episode of the NPR Politics Podcast sponsor-free, unlock access to bonus episodes with more from the NPR Politics team, and support public media when you sign up for The NPR Politics Podcast+ at plus.npr.org/politics.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Dragonfly raises a $650M Fund IV amid crypto's institutional vs retail sentiment gap, the industry exodus including Kyle Samani's departure from Multicoin, OpenClaw's OpenAI acquisition and crypto Twitter harassment, X402 payment standards for AI agents, Polymarket's controversial 5-minute Bitcoin betting markets, and the brewing federal vs state regulation battle over prediction markets. Welcome to The Chopping Block — where crypto insiders Haseeb Qureshi, Tom Schmidt, Tarun Chitra, and Robert Leshner chop it up about the latest in crypto. This episode kicks off with major news: Dragonfly just closed their $650 million Fund IV, making them one of the largest crypto VCs not through growth, but because others have downsized. The timing feels surreal — they keep raising right when markets dump, creating the biggest gap between institutional optimism and retail sentiment Haseeb has ever seen. But money flowing in contrasts sharply with talent flowing out. Kyle Samani left Multicoin, Arianna Simpson departed A16z Crypto, and several other crypto veterans are moving on. The crew unpacks what this "great resignation" means for an industry that feels like it's shifted from pioneer phase to settler phase. Then they dive into the OpenClaw saga — the viral AI coding assistant that got acquired by OpenAI, but not before its creator almost deleted it due to harassment from crypto Twitter demanding he launch a token. This leads to a deep discussion on X402 payment standards and why AI agents might prefer crypto over credit cards. Finally, they debate Polymarket's controversial 5-minute Bitcoin betting markets and the brewing legal battle between federal and state regulation of prediction markets. Let's get into it. Listen to the episode on Apple Podcasts, Spotify, Pods, Fountain, Podcast Addict, Pocket Casts, Amazon Music, or on your favorite podcast platform. Show highlights

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

In February 2026, Ghislaine Maxwell appeared virtually from a federal prison in Texas and repeatedly invoked the Fifth Amendment, refusing to answer questions about Jeffrey Epstein or any potential co conspirators. Through her attorney, however, she sent a message that immediately reignited controversy. Grant her clemency, and she will speak fully and honestly.Maxwell is currently serving a twenty year sentence for her role in recruiting and grooming underage girls for Epstein. With Epstein deceased and no additional federal indictments pending, she remains the only person imprisoned in connection to the case. Her proposed clemency deal raises difficult questions about accountability, leverage, and whether new information could ever lead to further charges.At the same time, newly released documents have fueled public debate. Emails, flight records, and references to powerful individuals have resurfaced. Federal prosecutors previously stated that while substantial evidence confirmed abuse of minors, they did not find sufficient provable evidence to bring additional federal conspiracy charges.Now the woman at the center of one of the most controversial cases in modern history is offering information in exchange for freedom. The government must decide whether the potential value of her testimony outweighs the gravity of her conviction.More than two decades after the first report in Palm Beach, the Epstein case continues to raise legal, political, and ethical questions that remain unresolved.

Last August, a van carrying seven farmworkers in rural Marion County was stopped by immigration agents. OPB reported on the arrest of the farmworkers, including a man identified as LJPL in court documents. He was arrested even though he had no criminal record and had a pending asylum application. That case and others involving the arrests of workers at dairy farms in Wisconsin and Vermont and a beef processing facility in Nebraska are described in a recent article by Investigate Midwest. The investigation offers a rare glimpse into how the Trump administration’s aggressive immigration enforcement tactics are playing out in rural farming communities in different states.    It found, for example, that these arrests happen even when immigration agents know that the individual has no criminal record. Attorneys also face obstacles getting access to their clients to challenge their detentions before they’re moved across state lines or deported. Meanwhile, the immigration raids are leaving employers such as family-owned farms and meatpacking plants scrambling to fill shifts or find reliable, non-immigrant labor for these jobs.   Sky Chadde, senior reporter at Investigate Midwest, joins us to share more details.

David Waldman counts down to the weekend, when we can all kick back, relax, and be incinerated in man-made hellfire…. but don't forget Friday's show! The law must take its course, as even His Majesty the King will tell you, no one is above the law, not even his very own brother, Andrew Mountbatten-Windsor. If only we had the moral rectitude of our forbearers, yet we invent new unaccountable elites every day. Still, around the world executives resign from companies as if they were ungrateful that Jeff made them who they are today. We could've handled it like Great Briton. We could've handled it like South Korea. We could've handled it like Brazil. Greg Dworkin culls the shiniest kernels out of his Ex-Twitter turd to share today. Democrats are job creators. House members get out while the getting's good. James Talarico is hot, hot, hot!  Gop Texans self-immolate.  Kristi Noem diverted a Coast Guard aircraft from an active search and rescue mission in order to transport detained migrants rather than share her double bidet. Stephen Miller, however, shows no inclination in retiring to spend more time in Hell. A Federal judge has finally found a DOJ lawyer in contempt. Judges have rebuked Trump's mass detention of immigrants thousands of times, encouraging him to do worse, faster. Keep alert to any stormtrooper activity at all times. Donald K. Trump sure can destroy a lot of real lives with powers that are mostly in your imagination.

In the 5 AM Hour: Larry O’Connor and Alex Swoyer discussed: Q & A with ALEX SWOYER - Attorney, Washington Times Editor at Large, Legal affairs reporter, author of new book “Lawless Lawfare: Tipping the Scales of Justice to Get Trump and Destroy MAGA”, and podcast host of Court Watch with Alex Swoyer SOCIAL MEDIA: https://x.com/ASwoyer Nancy Guthrie disappearance: Sheriff pleads with suspect to ‘just let her go,’ insists case not cold Federal judge rules Kilmar Abrego Garcia can’t be re-detained by immigration authorities Where to find more about WMAL's morning show: Follow the Show Podcasts on Apple podcasts, Audible and Spotify. Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @Jgunlock, @patricepinkfile, @Aswoyer and @heatherhunterdc. Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Show Website: https://www.wmal.com/oconnor-company/ How to listen live weekdays from 5 to 9 AM: https://www.wmal.com/listenlive/ Episode: Thursday, February 19, 2026 / 5 AM HourSee omnystudio.com/listener for privacy information.

Norfolk Southern and CMA CGM have announced a partnership to launch a new "truck-like" intermodal service connecting the Port of Los Angeles to key Midwest markets. This door-to-door option utilizes high-cube containers to offer the flexibility of trucking while reducing emissions through the rail network. Federal investigators are cracking down on safety violations with a massive sting operation targeting sham CDL training schools across the United States. The FMCSA has issued notices to more than 500 providers accused of using unqualified instructors and fast-tracking unprepared drivers onto the road. FedEx is signaling a major shift in strategy by doubling down on premium surcharges and moving away from subsidized low-cost shipping. The company plans to prioritize high-margin sectors like healthcare and heavyweight goods to drive profitability over volume. Follow the FreightWaves NOW Podcast Other FreightWaves Shows Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's Consumer Finance Monitor podcast, we are releasing an episode about a timely and wide-ranging discussion on one of the most significant and fastest-evolving developments in commercial finance: the rapid "consumerization" of small business lending law. In this episode, host Alan Kaplinsky welcomes Louis Caditz-Peck, Executive Director of the Responsible Business Lending Coalition (RBLC), for an in-depth conversation about the proliferation of state small business lending protection statutes, the policy debates driving them, and what they mean for lenders, fintechs, banks, and small business borrowers. From Self-Regulation to State Law: How We Got Here For decades, commercial lending operated under a fundamentally different regulatory framework than consumer credit. The prevailing assumption was that business borrowers were sophisticated, negotiated their transactions, and did not need standardized disclosures or suitability-type protections. That assumption has eroded. As Louis explains, since the financial crisis, and particularly with the growth of online and fintech lending, small business financing has changed dramatically. Community banks have pulled back. Non-bank online platforms have expanded. New products, including merchant cash advances and other revenue-based financing arrangements, have proliferated. At the same time, concerns have grown about: Opaque pricing structures Misleading "interest rate" representations Broker incentives that steer borrowers into higher-cost products Repeated refinancing of unaffordable obligations These concerns led to the development of the Small Business Borrower's Bill of Rights, a set of industry standards first launched in 2015 at the Aspen Institute by a coalition of lenders, small business groups, and nonprofit advocates. What began as a voluntary, self-regulatory effort quickly became a blueprint for legislation. California's SB 1235 in 2018 marked the first major small business truth-in-lending law. Since then, according to Louis, 19 small business financial protection laws have been enacted across multiple states, with California and New York leading the way. The "Consumerization" of Small Business Lending A central theme of the episode is whether we are witnessing the "consumerization" of small business lending. Many of the new state laws borrow heavily from consumer credit concepts, including: APR-style cost disclosures Total cost of financing disclosures Payment schedule requirements Prepayment and fee transparency Restrictions on certain contractual provisions Some states have layered on licensing or registration requirements for small business finance providers. Others incorporate or supplement state UDAP (unfair and deceptive acts and practices) standards, which may apply to certain business-to-business transactions as well as consumer transactions. The policy rationale is straightforward: many "Main Street" businesses are effectively sole proprietorships or closely-held operations without in-house finance or legal teams. Legislators increasingly view these borrowers as closer to consumers than to large corporations with treasury departments and inside or outside counsel. As Alan and Louis discuss, the regulatory shift raises serious operational and compliance challenges, particularly given the state-by-state patchwork of requirements. The Compliance Conundrum: Patchwork and Harmonization A recurring concern is whether the proliferation of state laws imposes disproportionate burdens on smaller lenders and startups, especially compared to large institutions with robust legal and compliance infrastructures. Louis emphasizes that RBLC has actively worked to promote interstate harmonization, particularly between California and New York. For example: Advocating for standardized disclosure forms that can be used in multiple states Aligning definitions and disclosure triggers Encouraging estimated APR calculations for revenue-based financing However, not all states have followed a harmonized approach. Some laws, particularly those focused narrowly on merchant cash advances, have created divergent requirements, complicating multi-state compliance. As Alan notes, the trend presents both risk and opportunity for lenders and their counsel. The regulatory environment is no longer static. Companies offering small business financing must assume that: Cost disclosures will likely be required in more states Registration or licensing may apply Enforcement risk—particularly under state UDAP statutes—will increase Section 1071 and Federal Uncertainty The episode also explores the role of the CFPB under Section 1071 of the Dodd-Frank Act, which requires data collection on small business lending to: 1.     Identify potential discrimination, and 2.     Assess whether certain markets are underserved. The CFPB finalized its 1071 rule in 2023 under then Director Rohit Chopra. Multiple legal challenges followed. Under the current administration, a notice of proposed rulemaking has sought to scale back and slow implementation. At the same time, the Federal Trade Commission has signaled an interest in using its enforcement authority to address unfair or deceptive acts or practices affecting small businesses—underscoring an intriguing tension within federal regulatory policy. As Louis observes, the debate is not simply about reducing or expanding government. It is about how government authority will be used and whether transparency and enforcement will be advanced through rulemaking, litigation, or state initiatives. Merchant Cash Advances and Revenue-Based Financing A particularly nuanced part of the discussion focuses on merchant cash advances (MCAs) and other sales-based financing products. These arrangements typically involve: An advance of funds in exchange for a fixed repayment amount Payments tied to a percentage of daily or periodic sales Variable duration depending on business performance RBLC's position, as Louis explains, is product neutral. The coalition does not advocate banning product categories or imposing rate caps. Instead, it focuses on responsible practices, including transparent pricing and assessment of ability to repay. Importantly, none of the major state lending protection laws impose interest rate caps. The emphasis is on disclosure and market transparency rather than price regulation. Who Is Covered—and Who Is Not? Most state small business truth-in-lending statutes apply to financing of $500,000 or less (with some variation, such as New York's $2.5 million threshold following gubernatorial revision). Coverage often includes: Closed-end loans Open-end lines of credit Sales-based financing/MCAs Factoring (in some states) Banks are generally exempt from these statutes, though non-bank "providers" presenting the offer of credit may still have disclosure obligations even in bank partnership models. As Alan highlights, this raises interesting competitive and policy questions about level playing fields across banks and non-banks. Looking Ahead to 2026 Both speakers agree: this trend is not going away. With significant percentages of small business owners reporting difficulty accessing affordable capital—and a substantial minority reporting harm from predatory practices—state legislators remain motivated to act. The key policy question is not whether regulation will expand, but how. Well-designed transparency frameworks can: Promote price competition Reward responsible innovation Improve borrower decision-making Poorly harmonized or overly rigid frameworks, however, risk increasing compliance costs and reducing credit availability. As Alan notes in his closing remarks, small business finance regulation is becoming a core area of growth for law firms and compliance professionals historically focused on consumer financial services. The line between consumer and commercial finance continues to blur.  Alan noted that the Consumer Financial Services Group which he founded and chaired for 25 years has counseled and represented small business lenders for decades. For lenders, fintechs, banks, and their advisors, understanding these developments is no longer optional—it is essential. Consumer Finance Monitor is hosted by Alan Kaplinsky, Senior Counsel at Ballard Spahr, and the founder and former chair of the firm's Consumer Financial Services Group. We encourage listeners to subscribe to the podcast on their preferred platform for weekly insights into developments in the consumer finance industry.

Jeffrey Epstein was found dead in his cell at the Metropolitan Correctional Center in Manhattan on August 10, 2019. The official ruling by New York City's chief medical examiner classified the death as suicide by hanging. Federal investigations later cited a series of institutional failures inside the jail, including malfunctioning cameras, guards who failed to conduct required checks, and Epstein's removal from suicide watch shortly before his death. The Department of Justice's inspector general described the episode as a cascade of negligence and staffing breakdowns rather than evidence of a coordinated plot. Two correctional officers were charged with falsifying records related to required monitoring rounds, further reinforcing claims of systemic dysfunction within the facility.Despite the official suicide determination, persistent public skepticism has fueled debate over whether Epstein could have been murdered. Critics point to the extraordinary number of powerful individuals linked to him, the unusual security lapses on the night of his death, and inconsistencies in early reporting as reasons to doubt the conclusion. Some forensic experts hired by Epstein's brother have argued that certain injuries were more consistent with homicide, though those findings have not overturned the medical examiner's ruling. The controversy has become emblematic of broader distrust in institutions, with many people viewing the unanswered questions surrounding Epstein's death as symbolic of deeper failures in accountability and transparency.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

A Willcox man will spend the next 13 years in federal prison for robbing a Safford bank, while his alleged accomplice prepares to stand trial next month.Support the show: https://www.myheraldreview.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

Send a textIn this episode of LFTG Radio, Elliott Carterr connects live with Pearlie “Larry Love” Johnson and his people as they revisit Johnson's 2008 federal trial in the Eastern District of New York and the fallout it created back home.The conversation centers on Jovane Jenkins, who appeared on the government's witness list and took the stand during the trial. From there, Larry and the others speak bluntly about what courtroom testimony means in their world — drawing a hard line between “the streets” and “the sidewalk,” calling out what they see as excuse-making, and describing how “paperwork culture” reshapes reputations long after sentencing.It's a raw, unfiltered look at how federal trials echo through neighborhoods: loyalty vs. survival, credibility vs. politics, and why one witness's testimony can divide entire circles for years.(Note: Characterizations and labels used in the episode reflect the speakers' views and the public narrative surrounding the case.)Support the show

As Trump edges toward conflict with Iran, Houston activists mobilize against ICE while the administration expands federal control over elections before the midterms.Subscribe to our Newsletter:https://politicsdoneright.com/newsletterPurchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make AmericaUtopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And BeFit Now: https://amzn.to/3xiQK3K Tribulations of anAfro-Latino Caribbean man: https://amzn.to/4c09rbE

Confira os destaques de Os Pingos nos Is desta quarta-feira (18):A Acadêmicos de Niterói terminou a apuração do Carnaval do Rio de Janeiro na última colocação e foi rebaixada após levar à Marquês de Sapucaí um desfile em homenagem ao presidente Lula (PT). A apresentação já havia gerado controvérsias antes mesmo de entrar na avenida, com questionamentos sobre possível propaganda eleitoral antecipada e debates sobre judicialização do caso. Frentes parlamentares cristãs criticaram o desfile da escola Acadêmicos de Niterói em homenagem ao presidente Lula (PT) no Carnaval do Rio e anunciaram a possibilidade de medidas judiciais. As críticas se concentram em uma ala que teria feito sátiras a famílias evangélicas, o que motivou notas de repúdio, pedidos de apuração e manifestações de entidades jurídicas sobre possível preconceito religioso. O Banco Central decretou a liquidação extrajudicial do Banco Pleno, instituição que já integrou o conglomerado do Banco Master, investigado por supostas fraudes financeiras. A medida ocorre após dificuldades de liquidez e restrições para emissão de novos títulos, enquanto o impacto das liquidações de bancos ligados ao grupo pode alcançar cerca de R$ 52 bilhões no Fundo Garantidor de Crédito. A defesa do ex-presidente do Banco de Brasília, Paulo Henrique Costa, solicitou que ele seja novamente ouvido pela Polícia Federal no inquérito que investiga supostas fraudes financeiras envolvendo o BRB e o Banco Master. O pedido foi feito após acareação determinada pelo STF, e a investigação segue agora sob relatoria do ministro André Mendonça. O presidente Lula vetou parcialmente projetos que previam reajustes de até 90% para servidores da Câmara, do Senado e do TCU, além de benefícios que poderiam elevar vencimentos acima do teto constitucional. A decisão ocorre em meio ao debate sobre gastos públicos e ainda pode ser analisada pelo Congresso, que tem poder para derrubar o veto. O PT avalia que o calendário eleitoral pode adiar a análise, pelo Congresso, dos vetos do presidente Lula a benefícios e reajustes do Legislativo. A expectativa é de que parlamentares evitem desgaste público ao tratar do tema, enquanto lideranças partidárias discutem prioridades e possíveis articulações em torno da manutenção ou derrubada das decisões presidenciais. O vereador Carlos Bolsonaro afirmou ter encontrado o ex-presidente Jair Bolsonaro “sonolento e abatido” durante visita no complexo penitenciário da Papuda. Segundo o parlamentar, o pai mantém rotina com itens pessoais permitidos e refeições enviadas pela família, em meio às discussões sobre a situação jurídica e possíveis pedidos de prisão domiciliar. O conselheiro do presidente Lula e ex-presidente da Câmara, João Paulo Cunha, afirmou que o senador Flávio Bolsonaro seria um adversário mais difícil do que o governador de São Paulo, Tarcísio de Freitas, em uma eventual disputa presidencial. Segundo ele, fatores como rejeição consolidada, nível de conhecimento nacional e histórico eleitoral influenciam o cenário para as eleições de 2026.Você confere essas e outras notícias em Os Pingos nos Is.

Di vê bûletene de: Opozîsyona Federal dibêje divê pasaport ji jin û zarokên ku bi koma Dewleta Islamî (DAIŞ) ve girêdayî ne nehatibûna dayîn... Adelaide dê ji sala 2027an pê ve mazûvaniya MotoGP bike... Û Mary Flower di tîmê Matildas de ji bo Kûpa Asyayê ya meha bê hat hilbijartin. Ew nûçeyana û nûçeyên din di bûlentenê de hene.

Thank you Michael Catlett, Marg KJ, Laura

Story 1: Neighborly disputes can be a headache, but rarely do they result in a potential public health emergency. For one Las Vegas neighborhood however, the improbable became reality. Congressman Kevin Kiley (R-CA) joins Will to help decipher the mystery behind illicit biolabs in the western United States, each containing samples of highly infectious diseases, and operated by the same Chinese national.Story 2: Democratic Representative in Texas and Will Cain antagonist James Talarico (D-TX) made headlines this week after his interview with Stephen Colbert was pulled, making the bold claim that the Federal government personally ordered its cancellation. The evidence, and even some in his own party, would beg to differ. Will and The Crew unravel Rep. Talarico's Machiavellian political plays in the wake of his interview's cancellation, and explain the real reason why it was pulled.Story 3: Will and The Crew take a look at a recent study demonstrating a massive explosion in LGBT identity among younger generations, and hear Will out on his billion dollar restaurant idea. Subscribe to ‘Will Cain Country' on YouTube here: ⁠⁠⁠⁠⁠Watch Will Cain Country!⁠⁠⁠Follow ‘Will Cain Country' on X (⁠⁠⁠@willcainshow⁠⁠⁠), Instagram (⁠⁠⁠@willcainshow⁠⁠⁠), TikTok (⁠⁠⁠@willcainshow⁠⁠⁠), and Facebook (⁠⁠⁠@willcainnews⁠⁠⁠)Follow Will on X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@WillCain⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Retired agent Jerry Spurgers reviews his investigation of the mysterious disappearance of federal witness Susan Cooper from Malvern, Arkansas. The case involved drug conspiracy, witness intimidation, and murder. Jerry investigated the case with a team of local officers, sheriff's deputies, and an intelligence analyst by using traditional police skills and new technologies. As a former member of the Little Rock Division's Evidence Response Team and an experienced death investigator, he also reviews the steps taken to collect evidence at a murder or accidental death. Jerry is the author of Murder at Midnight: The FBI's Battle with Violence and Drugs in a Small Southern Town, a true crime book about the investigation. He served in the FBI for 24 years. Check out episode show notes, photos, and related articles: https://jerriwilliams.com/388-jerry-spurgers-disappearance-and-murder-of-federal-witness-death-crime-scenes/       Join my Reader Team to get the FBI Reading Resource - Books about the FBI, written by FBI agents, the 20 clichés about the FBI Reality Checklist, and keep up to date on the FBI in books, TV, and movies via my monthly email. Join here. http://eepurl.com/dzCCmL    Buy me a coffee - https://www.buymeacoffee.com/JerriWilliams   Check out my FBI books, non-fiction and crime fiction, available as audiobooks, ebooks and paperbacks wherever books are sold. https://jerriwilliams.com/books/e

More Americans are blaming the AI infrastructure expansion for rising electricity bills. Our Head of Public Policy Research Ariana Salvatore explains how the topic may influence policy announcements ahead of the midterm elections.Read more insights from Morgan Stanley.----- Transcript -----Ariana Salvatore: Welcome to Thoughts on the Market. I'm Ariana Salvatore, Head of Public Policy Research for Morgan Stanley. Today I'll be talking about the relationship between affordability, the data center buildout, and the midterm elections. It's Wednesday, February 18th at 10am in New York. Markets and voters continue to grapple with questions on AI, including its potential scope, impact, and disruption across industries. That's been a clear theme on the policy side as voters seem to be pushing back against AI development and data center buildout in particular. In key states, voters are associating the rise in electricity bills with AI infrastructure – and we think that could be an important read across for the midterm elections in November. Now to be sure, electricity inflation has stayed sticky at around four to 5 percent year-over- year, and our economists expect it to remain in that range through this year and next. Nationally the impact of data centers on electricity prices has been relatively modest so far, but regionally, the pressure has been more visible. To that point, a recent survey in Pennsylvania found that nearly twice as many respondents believe AI will hurt the economy as it will help. More than half – 55 percent – think AI is likely to take away jobs in their own industry, and 71 percent said they're concerned about how much electricity data centers consume. But this isn't just a Pennsylvania story. In other battleground states like Arizona and Michigan, voters have actually rejected plans to build new data centers locally. So, what could that mean for the midterm elections? Think back to the off-cycle elections in November of last year. Candidates who ran on this theme of affordability and actually pushed back against data center construction tended to do pretty well in their respective races. Looking ahead to the midterm elections later this year, we see two clear takeaways from a policy perspective. First, it's important to note that more of the policy action here will actually continue to be at the local rather than federal level. Some states with heavy data center build out – so Georgia, Michigan, Ohio, and Texas among others – are now debating who should pay for grid upgrades. Federal proposals on this topic are still pretty nascent and fragmented. Meanwhile, public utility commissions in states like Georgia, Ohio, Michigan, and Indiana have adopted or proposed large load tariffs. These require data centers to shoulder more upfront grid costs; or can reflect conditional charges like long-term contracts, minimum demand charges, exit fees or collateral requirements – all of which are designed to prevent costs from spilling over to households. And secondly, because of that limited federal action, we expect the Trump administration to continue leaning on other levers of affordability policy, where the president actually does have some more unilateral control. We've been expecting the administration to continue focusing on broader affordability areas ranging from housing to trade policy, as we've said on this podcast in the past. That dynamic is especially relevant this week as the Supreme Court could rule as soon as Friday on whether or not the president has the authority under IEEPA to impose the broad-based reciprocal tariffs. The administration thus far has been projecting a message of continuity. But we've noted that a decision that constrains that authority could give the president an opportunity to pursue a lighter touch tariff policy in response to the public's concerns around affordability. That's why we think the AI infrastructure buildout debate will continue to be a flashpoint into November, especially in the context of rising data center demand. Next week, when the president delivers his State of the Union address, we expect to hear plenty about not just affordability, but also AI leadership and competitiveness. But an equally important message will be around the administration's potential policy options to address its associated costs. That tension between AI supremacy and rising everyday costs for voters will be critical in shaping the electoral landscape into November. Thanks for listening. As a reminder, if you enjoy Thoughts on the Market, please take a moment to rate and review us wherever you listen; and share Thoughts on the Market with a friend or colleague today.

The Anna Kepner case is one of the most opaque investigations in recent true crime history—and defense attorney Bob Motta explains why.Anna, 14, died aboard the Carnival Horizon in November 2024. The medical examiner ruled it homicide by mechanical asphyxiation, reportedly caused by a bar hold restraint. Three months later, her 16-year-old stepbrother appeared in federal court. He was released to guardian custody. No charges have been publicly confirmed. Everything is sealed under federal juvenile protection laws.Bob breaks down what sealed proceedings mean in practice—the courtroom mechanics, the information blackout, the legal rationale for protecting juvenile defendants. He addresses the family's contradictory public statements and explains why confusion about charges is common in these cases.The jurisdictional decision matters: the FBI could have handed this to state prosecutors but chose to keep it federal. That choice tells us something about how the government views the seriousness of what happened in that cabin.Details have emerged through custody proceedings. Text messages revealed the suspect reportedly claims no memory of the night Anna died. Testimony indicated he had ADHD and was on insomnia medication he allegedly hadn't taken for two nights on the cruise, including the night before the discovery. Bob analyzes how these factors might figure into a defense strategy.The family dynamic is extraordinary: the suspect's biological mother is married to the victim's father. They've jointly called for accountability. This creates complications unlike anything either side has likely encountered.This is the legal context you need as this case moves forward.#AnnaKepner #CarnivalHorizon #TrueCrimeToday #FederalCase #SealedProceedings #JuvenileJustice #CruiseShipDeath #FBIInvestigation #LegalAnalysis #HiddenKillersJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.

40 years inside the Hells Angels. Federal murder conspiracy charges. Bombings, informants, and a courtroom showdown with the U.S. government. In this raw, unfiltered interview, longtime Ventura Hells Angels leader George Christie tells the inside story of outlaw biker life — from the brotherhood and early motorcycle culture to violent club wars, federal investigations, and the high-stakes legal battles that nearly destroyed his life. He reveals what it was really like to: • Rise through the ranks of a legendary 1% motorcycle club • Survive assassination attempts and clubhouse bombings • Face multiple federal prosecutions — and beat them • Navigate informants, undercover operations, and government pressure • Witness the evolution of biker culture from brotherhood to organized crime conflicts This is a rare, firsthand account of one of America's most controversial subcultures — told by someone who lived it for decades. Go Support George! Website: https://www.georgechristie.com/ IG: https://www.instagram.com/georgechristiejr/ YouTube:  @GeorgeGusChristie  Join The Patreon For Bonus Content! https://www.patreon.com/theconnectshow 00:00 Meet George Christie: Outlaw Legend 02:00 Early Days & Biker Culture Origins 06:00 Joining the Hell's Angels 10:00 Brotherhood, Bikes, and Old School Rules 14:00 Outlaw Clubs: From Bonding to Violence 21:00 Criminal Elements & Club Evolution 26:00 Club Wars, Prison, and Peace Efforts 33:00 Bombings, Feds, and Surviving the System 38:00 Government Tactics and Lawfare 45:00 Murder Conspiracy Case and Beating the Feds 55:00 Life After the Big Trial 01:03:00 Entrepreneurship, Fame, and More Heat 01:09:00 Running Ventura & The Power of Reputation 01:13:00 Dealing with Informants and Police 01:19:00 Courtroom Battles, Sons of Anarchy, and Pop Culture 01:29:00 Club Exit, Reflections & Writing the Story 01:34:00 Modern Times, Legacy & Final Thoughts Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sealed court. No public charges. A suspect released to guardian custody. The Anna Kepner case is unfolding almost entirely behind closed doors—and defense attorney Bob Motta explains what that means.Anna Kepner, 14, died aboard the Carnival Horizon in November 2024. The medical examiner ruled it homicide by mechanical asphyxiation—reportedly a bar hold restraint. Her 16-year-old stepbrother appeared in federal court on February 6th, 2025, three months after her death. Everything since has been sealed under federal juvenile protection laws.Bob walks through what actually happens in these sealed proceedings—the courtroom dynamics, the restrictions on information, why federal law treats juvenile defendants differently than adults. He addresses the family's contradictory public statements and explains how little information typically reaches families during federal juvenile cases.The FBI kept this case federal instead of turning it over to state prosecutors. That decision tells us something about how the government assesses the severity. Bob breaks down the factors that influence that jurisdictional call.Text messages from custody proceedings revealed the suspect reportedly claims no memory of the night Anna died. Testimony indicated he had ADHD and was on insomnia medication he allegedly hadn't taken for two nights on the cruise. Bob analyzes whether either factor could support a defense strategy—and the complications that arise.The family dynamic is extraordinary: the suspect's biological mother and the victim's father are married. They've jointly called for accountability. That creates unprecedented complications for defense and prosecution alike.This is what we know, what we can infer, and what comes next.#AnnaKepner #CarnivalHorizon #SealedCase #FederalJuvenileCourt #CruiseShipDeath #MechanicalAsphyxiation #JuvenileDefense #LegalAnalysis #TrueCrime #HiddenKillersJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.

February 18, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Americans now spend 6.3 hours daily on phones, up from 5.5 hours in early 2023, with older users driving surge Raw sugar futures fall to five-year low as GLP-1 drugs accelerate decline in sweet consumption while whey prices hit record highs Federal law caps THC in hemp products near zero in November, potentially eliminating much of $8-13B CBD market I'm heading to LA this week for the Connected Health & Fitness Summit to host a fireside chat with Fritz Lanman, CEO of Playlist (parent company of Mindbody and ClassPass), on AI in fitness and the anticipated $7.5B EGYM merger. If you're attending or based in LA and want to meet up, email team@fitt.co. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

Federal fisheries regulators approved some limits on Western Alaska chum bycatch in the Bering Sea last week. The highly debated – and long awaited – decision aims to protect declining salmon stocks, a crucial food resource for Alaska tribes. The Alaska Desk’s Alena Naiden from our flagship station KNBA has this story. The North Pacific Fishery Management Council voted to set a Western Alaska chum bycatch limit in the Bering Sea pollock fishery. The council said the move will balance protections for Western Alaska salmon returns, while also allowing pollock fisheries to continue their harvest. Council member Nicole Kimball voted for the motion. She says it addresses those needs and reflects best available Western and Indigenous science. “I think it’s going to change behavior. I think it’s going to reduce Western Alaska chum bycatch … I’m sure, as per usual, nobody is very happy, but all of the discussions have really helped … inform the outcome.” The trawl fishery in the Bering Sea near the Aleutian Islands is focused on pollock, but boats also scoop up other types of fish. That includes chum salmon, some of which migrates to Western and Interior Alaska rivers and is a crucial subsistence resource there. But chum runs have been declining, leading to repeated fishing closures in some communities. Alaska Native Council member John Moller, originally from Unalaska, is a commercial fisherman. He says he is fortunate to put fish up each year and feels for those who cannot. “I know how important that is to me, how important that is to my family, and passing that on to my children – I get that. And my heart is ripped out, speaking with all of you that are living on the rivers right now that don’t have that same ability that I have living in Southeast.” The council voted to support a motion that sets a limit to Western Alaska chum bycatch. Exceeding that limit would trigger a partial closure. Rachel Baker is the Deputy Commissioner at Alaska Department of Fish and Game. She presented the motion. Several members who voted against the motion said it is not likely to provide a meaningful improvement for salmon returns, but Baker argued. “We’re at this table used to thinking about large volumes of fish, in tons … we heard in testimony that four fish were able to provide the needs for a potlatch.” The plan goes to the National Marine Fisheries Service next before it can be implemented. (Courtesy AMC) This weekend saw the recent premiere of Season 4 of AMC's award-winning detective drama, “Dark Winds” which takes place in 1970s Navajo Country. As Brian Bull reports, tension and resentment threaten the romantic relationship between two main characters. After Bernadette Manuelito quits the U.S. Border Patrol and returns to the Navajo Tribal Police Department, it looks like a carefree and intimate rekindling of her romance with fellow officer, Jim Chee. But Lt. Joe Leaphorn shares a life decision with Manuelito that will shake up the force, a secret which Chee inevitably learns. Feeling affronted and mistrusted, a schism occurs between the couple. Actors Kiowa Gordon and Jessica Matten talk about bringing this conflict to their characters. “Leaphorn's coming from a place of understanding the matriarchy system, and in order to protect this relationship dynamic, she doesn't feel like she's lying to Chee, she feels like she's actually protecting him from what he doesn't need to know.  Y'know she's dealing with a lot of the PTSD of her just killing a man in season 3, and sometimes you just don't want to tell the truth right away because you might actually spiritually just drown, because it’s too much.” “And he is dealing with his own demons that he's been pushing away but now they've come to collect. And having to deal with that and trying to maintain your professionalism when you're working with the love of your life at the same time, and so there's a lot of dynamics being played out.” (Courtesy AMC) Meanwhile, an investigation takes the pair and Leaphorn to Los Angeles. Gordon and Matten say much of the filming still happened in New Mexico, parts of which resembled L.A. more than 50 years ago. New episodes of “Dark Winds” air Sunday nights on AMC and a fifth season has already been greenlit. The premiere episode of “Dark Winds” season 4 ended with a tribute to executive producer Robert Redford, who passed away last September. (Courtesy AMC) Get National Native News delivered to your inbox daily. Sign up for our daily newsletter today. Download our NV1 Android or iOs App for breaking news alerts. Check out today’s Native America Calling episode Wednesday, February 18, 2026 – Native in the Spotlight: Keeya Wiki

Everything about the Anna Kepner case is sealed—but defense attorney Bob Motta can still explain what's happening and what comes next.Anna Kepner, 14, died aboard the Carnival Horizon in November 2024. The medical examiner ruled it homicide by mechanical asphyxiation. Her 16-year-old stepbrother appeared in federal court on February 6th, 2025, and was released to guardian custody on pretrial supervision. No charges have been publicly confirmed. The family's own statements have contradicted each other.Bob joins us live to break down federal juvenile proceedings—what happens in that courtroom, why everything is sealed, and what information families typically receive. He explains the FBI's decision to keep this case federal rather than handing it to state prosecutors, and what that jurisdictional choice signals about the government's assessment.Text messages from custody proceedings revealed the suspect reportedly claims no memory of the night Anna died. Testimony indicated he had ADHD and hadn't taken his insomnia medication for two nights on the cruise. Bob analyzes these potential defense factors in real time.The family situation is unlike anything we've seen: the suspect's biological mother is married to the victim's father. They've jointly called for accountability—meaning the suspect's own mother is publicly supporting his prosecution. Bob addresses how this extraordinary dynamic affects both defense and prosecution strategies.We take your questions and provide analysis as this case moves toward its next phase.#AnnaKepner #CarnivalHorizon #LiveAnalysis #FederalJuvenileCase #CruiseShipHomicide #SealedProceedings #DefenseAttorney #HiddenKillersLive #TrueCrime #LegalBreakdownJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.

More federal funding for public health is on the chopping block. MPR News host Angela Davis talks about what the cuts could mean for Minnesota and why a federal judge stepped in to temporarily block them. 

One of the hottest topics in college athletics turns out to be about nonprofits. This episode unpacks how nonprofit colleges and third-party NIL collectives support individual student athletes, the governance and tax questions that follow, and what the recent NCAA settlement means for oversight and compliance. We also look ahead to emerging federal regulation and how nonprofits might engage in shaping what comes next.   Attorneys for this Episode ·      Tim Mooney ·      Victor Rivera   Why NIL Is a Nonprofit Issue  ·       Define NIL: athlete rights to monetize their brand (name, image, likeness). ·       Distinguish third-party deals vs. institution-linked compensation ·       Why nonprofits are in the mix: NIL collectives, booster organizations, independent sponsorscirculating capital in the ecosystem. College athletics live inside nonprofit institutions — universities and colleges are almost all 501(c)(3)s. Enter third-party NIL collectives — many of which are also nonprofits, often organized as 501(c)(3)s or seeking that status. When nonprofits move money, governance and tax law always follow — NIL is no exception. In October 2025, a settlement in House v. NCAA settlement centralized review mechanisms (the College Sports Commission – or CSC) now oversee deal approvals & compliance. Ongoing federal intervention: the proposed SCORE Act is NCAA-backed and would stop athletes from being considered employees and shield the NCAA from the kinds of class action lawsuits that got us to the current NIL landscape   How Nonprofits End Up Supporting Individual College Athletes Nonprofits can and do financially benefit specific individuals (scholarships, disaster relief, housing aid, fellowships). NIL collectives operate on a similar theory: Supporting athletes through appearances, community engagement, or promotional activity Often tied (explicitly or implicitly) to institutional athletic programs The tension: Supporting individuals is allowed But private benefit, inurement, and mission drift are still red lines Issue with compensating individuals using their "fair market value" Key question for nonprofits: Are we advancing a charitable purpose (legal) or just subsidizing compensation (questionable)? Governance Questions Nonprofits Can't Ignore Board-level responsibilities Mission alignment How does athlete support further the stated charitable purpose? Is this education, community engagement, economic equity or something else? "Amateur athletics" does a lot of heavy lifting here, but sometimes the collectives compensate the athletes for promoting charitable events/causes. Board oversight Who approves NIL strategy? How are conflicts of interest handled (especially boosters, alumni, donors)? Controls and accountability Criteria for selecting athletes Documentation of services provided Fair market value analysis Transparency What are donors told? What is disclosed publicly vs. internally? Regulation on the Horizon After the NCAA Settlement The NCAA settlement signals: More centralized oversight More formal review of NIL arrangements Less tolerance for "wink-and-nod" structures Likely regulatory pressure points: Standardized deal review Clearer definitions of permissible activity Increased scrutiny of nonprofit status and operations Should Nonprofits Weigh In on What Comes Next? The NCAA settlement last fall quieted things down by creating reporting structures, arguably with some teeth. But as things evolve, there's more space for nonprofits in particular to notice. Will the College Sports Commission (CSC) continue to have conference support so it can enforce the NIL rules? The agreement hasn't been fully adopted yet, but the CSC is already knocking down some NIL deals. Federal legislation (SCORE Act or SAFE Act) Recent controversies surrounding eligibility of former pro-basketball players (Amari Bailey, Charles Bediako) may force Congress to act NCAA-adjacent rulemaking State-level NIL frameworks particularly regarding their institutions Other structures could allow potential pathways for unionization for student-athletes 501(c)(5)s like AFL-CIO have come out against SCORE Act Previous attempts have failed by student-athletes in Northwestern and in other universities and the SCORE Act has a provision that bans college athletes from being considered employees Resources NIL Compliance Tightens: What the NCAA's New Rules Mean for Institutions and Sponsors – Steptoe and Johnson College Sports Watchdog Will Enforce Rules Without Legal Backing – Front Office Sports NIL regulations for college athletes face hurdles in Congress – Spectrum News Letter Opposing Legislation That Would Be A Bad Deal for College Athletes – AFL-CIO

Six skiers rescued, nine others still missing after group is caught in Sierra avalanche; Can a Millionaires Tax help fix WA's affordability 'crisis?' Facing doctor shortage, lawmakers in MI explore who can fill the gap; Federal cuts renew push for MA medical debt protections.

O programa Meio-Dia em Brasília desta Quarta-Feira de Cinzas, 18, fala sobre a investigação contra quatro servidores da Receita Federal que foram acusados pelo ministro Alexandre de Moraes de acessar ilegalmente dados de integrantes do Tribunal.Além disso, o jornal também aborda as consequências do desfile eleitoreiro realizado pela Acadêmicos de Niterói no último domingo e as repercussões junto a integrantes da oposição.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br #STF #Moraes #PoliticaBrasil #Noticias

Uma operação da Polícia Federal deflagrada em plena terça-feira de Carnaval, por determinação do ministro Alexandre de Moraes, instaurou um clima de guerra e paranoia no Supremo Tribunal Federal.A suspeita que circula nos corredores de Brasília é de que Moraes estaria utilizando a estrutura da PF para monitorar e colher informações sobre seus próprios colegas de toga, sob o pretexto de investigar vazamentos. O movimento ampliou a desconfiança interna e quebrou qualquer resquício de união institucional que o presidente Edson Fachin tentava construir.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

No 3 em 1 desta quarta-feira (18), o destaque foi a Unidos do Viradouro, que é a grande campeã do Carnaval do Rio de Janeiro 2026 após uma disputa acirrada decidida apenas no último quesito da apuração. A escola conquistou seu quarto título na Sapucaí com um enredo que homenageou o Mestre Ciça, uma das maiores referências do samba. Por outro lado, a Acadêmicos de Niterói, que gerou polêmica ao levar o presidente Lula (PT) como enredo, acabou sendo rebaixada na competição deste ano. O presidente Lula (PT) sancionou, nesta quarta-feira (18), o projeto de reajuste salarial para servidores do Legislativo, mas vetou os chamados “penduricalhos”, que poderiam permitir que os salários dos servidores chegassem ao valor de R$ 80 mil. Além disso, o Partido dos Trabalhadores avalia que o ano eleitoral deve impedir a análise dos vetos. Reportagem: André Anelli. O Banco Central decretou a liquidação extrajudicial do Banco Pleno, marcando a sexta instituição ligada ao grupo do Banco Master a sofrer esse tipo de intervenção. O atual dono, Augusto Lima, chegou a ser preso no final de 2025 junto com Daniel Vorcaro, do Master, e hoje ambos cumprem medidas cautelares com o uso de tornozeleira eletrônica. Reportagem: Janaína Camelo. A Justiça dos Estados Unidos adiou a audiência de Nicolás Maduro, acusado de narcotráfico, do dia 17 para 26 de março. O ex-presidente venezuelano segue preso em Nova York, e a mudança foi solicitada pelo Ministério Público por questões logísticas e de planejamento processual, com aval da defesa e do juiz. Reportagem: Eliseu Caetano. O Vaticano anunciou que não vai participar do Conselho de Paz criado pelo presidente dos Estados Unidos, Donald Trump, que tem como objetivo intermediar conflitos globais. A posição da Igreja é de que as crises internacionais são administradas pela ONU, justificando a ausência na nova estrutura proposta pelos EUA. Reportagem: Luca Bassani. O Palácio do Planalto teme um possível desgaste na relação com o público evangélico após o desfile da escola de samba Acadêmicos de Niterói, na Sapucaí (RJ). O desfile, que teve o presidente Lula (PT) como enredo, gerou polêmica e pode ter acendido um alerta no governo sobre o impacto da homenagem junto aos setores religiosos. Reportagem: André Anelli. O diretor-geral da Polícia Federal, Andrei Rodrigues, viaja com o presidente Lula (PT) em uma agenda oficial pela Ásia, em meio a um cenário de forte tensão com o STF. Rodrigues tem sido alvo de críticas recorrentes devido ao relatório da corporação sobre o caso do Banco Master. Reportagem: André Anelli. O conselheiro de Lula (PT), João Paulo Cunha, afirmou que Flávio Bolsonaro (PL) seria o rival mais difícil para as eleições presidenciais de 2026. A análise estratégica aponta que enfrentar o senador seria um desafio maior do que disputar contra Tarcísio de Freitas (Republicanos). Reportagem: Matheus Dias. Tudo isso e muito mais você acompanha no 3 em 1. Learn more about your ad choices. Visit megaphone.fm/adchoices

No 3 em 1 desta terça-feira (17), o destaque foi a Polícia Federal que deflagrou nesta terça-feira (17), por determinação do ministro Alexandre de Moraes, uma operação para investigar o acesso ilegal e o vazamento de dados fiscais de ministros do STF, do Procurador-Geral da República, Paulo Gonet, e de seus familiares. O governador do Rio de Janeiro, Cláudio Castro (PL), reuniu-se com o senador Flávio Bolsonaro (PL) para alinhar os próximos passos da direita no estado para 2026. Em jogo está a decisão de Castro: permanecer no cargo até o fim do mandato ou renunciar para disputar uma das duas vagas ao Senado Federal. Os ministros André Mendonça e Luiz Fux, do Supremo Tribunal Federal (STF), cancelaram sua participação no II Congresso Ibero-Brasileiro de Governança Global, após a revelação de que o advogado Igor Tamasauskas, que defende o banqueiro Daniel Vorcaro (dono do Banco Master), presidiria uma das mesas do evento. Em entrevista ao 3 em 1, o jurista Adib Abdouni analisou a troca de relatoria no Caso Master, após o ministro André Mendonça assumir a cadeira de Dias Toffoli. Abdouni classificou a redistribuição do inquérito "a pedido" de Toffoli como uma "saída jurídica interessante" e estratégica para preservar a imagem do Supremo Tribunal Federal (STF) diante das citações do nome do ministro em relatórios da PF. O presidente Luiz Inácio Lula da Silva (PT) entra na reta final do prazo constitucional para sancionar ou vetar os projetos ligados aos penduricalhos. Acompanhe a análise da bancada sobre o tema. O Governo Luiz Inácio Lula da Silva (PT) prepara uma reforma ministerial forçada para o início de 2026. A previsão é de que mais de 20 ministros deixem a Esplanada para concorrer a cargos na Câmara, Senado e governos. O governador de Minas Gerais, Romeu Zema (Novo), afastou qualquer rumor sobre uma possível fragmentação da oposição para as eleições de 2026. Tudo isso e muito mais você acompanha no 3 em 1. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we break down the federal bribery indictment of former NYPD Inspector Kevin Taylor, the former Commanding Officer of the School Safety Division. Federal prosecutors allege Taylor accepted luxury travel to Las Vegas and the Bahamas, entertainment, and other benefits from a technology executive in exchange for using his official authority to influence NYPD procurement decisions including the expansion of a school panic-button system and a multimillion-dollar vest contract ️ New to streaming or looking to level up? Check out StreamYard and get $10 discount! https://streamyard.com/pal/d/5689366474915840 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This Day in Legal History: Aaron Burr Arrested (But Not For That)On February 18, 1807, former Vice President Aaron Burr was arrested in the Mississippi Territory on charges of treason against the United States. Once one of the most powerful men in the young republic, Burr had fallen from political grace after killing Alexander Hamilton in a duel and drifting to the margins of national life. Federal authorities accused him of plotting to carve out an independent nation in the western territories, possibly including lands belonging to Spain. The allegations sparked fear that the fragile Union could splinter only decades after independence.Later that year, Burr stood trial in Richmond, Virginia, before Chief Justice John Marshall, who was riding circuit. The case quickly became a constitutional showdown between executive power and judicial restraint. President Thomas Jefferson strongly supported the prosecution, but Marshall insisted that the Constitution's Treason Clause be applied strictly. The Constitution requires proof of an “overt act” of levying war against the United States, not merely evidence of intent or conspiracy.Marshall ruled that prosecutors had failed to present sufficient proof that Burr had committed such an overt act. As a result, the jury acquitted him. The decision established an enduring precedent that treason must be narrowly defined and carefully proven. By demanding clear evidence of action rather than suspicion or political hostility, the court reinforced limits on the government's power to punish alleged disloyalty. Burr's trial remains one of the earliest and most significant tests of constitutional safeguards in American legal history.Bayer AG and its Monsanto subsidiary have proposed a $7.25 billion nationwide class settlement to resolve current and future claims that Roundup exposure caused non-Hodgkin lymphoma. Filed in Missouri state court, the agreement would run for up to 21 years and provide capped, declining annual payments. People diagnosed before or within 16 years after final court approval could seek compensation through the program. The settlement must still receive judicial approval.The proposal is part of a broader strategy tied to the U.S. Supreme Court's pending review of Durnell v. Monsanto, which could determine whether federal pesticide labeling law blocks certain state failure-to-warn claims. Bayer has indicated that a favorable ruling could significantly limit future lawsuits, while the class program is designed to address claims regardless of the Court's decision. Plaintiffs' attorneys say the deal would cover both occupational and residential exposure and protect the rights of future claimants, while allowing individuals to opt out and pursue separate suits.Roundup litigation has generated tens of thousands of cases, with more than 40,000 already pending or subject to tolling agreements. Bayer inherited the legal challenges after acquiring Monsanto in 2018, and the ongoing litigation has weighed heavily on the company financially and reputationally. Previous jury verdicts have resulted in multibillion-dollar awards, some later reduced on appeal or by judges. The new proposal would replace an earlier settlement effort that collapsed in 2020 and aims to create a longer-term, more predictable compensation system.Bayer AG Unveils $7.3B Deal For Roundup Users - Law360Bayer proposes $7.25 billion plan to settle Roundup cancer cases | ReutersA Seattle federal jury found inventor Leigh Rothschild, several of his patent-holding companies, and his former attorney liable for violating Washington's anti-patent trolling law after asserting patent infringement claims against Valve Corp. Jurors concluded the defendants acted in bad faith under the Washington Patent Troll Prevention Act and also violated the state's consumer protection statute. Valve was awarded $22,092 in statutory damages.The jury also determined that Rothschild and his companies breached a 2016 global settlement and licensing agreement with Valve. Under that agreement, Valve paid $130,000 for rights to certain patents in exchange for a promise not to sue over them. Despite that covenant, Rothschild's entities later filed a 2022 infringement lawsuit and sent a 2023 letter threatening additional litigation. The jury awarded Valve $130,000 for the first breach and $1 for the second, finding no valid justification for repudiating the agreement.In addition, jurors ruled that one asserted patent claim was invalid because it would have been obvious to a skilled professional at the time of filing. The dispute stemmed from Valve's 2023 lawsuit accusing Rothschild of repeatedly pursuing claims covered by the prior settlement. The defense argued any mistakes were unintentional and not profit-driven, but the jury sided with Valve after a four-day trial.The case also involved procedural controversies, including sanctions over delayed financial disclosures and allegations that a defense filing contained fabricated quotations and citations generated by artificial intelligence. Post-trial motions are expected as the defense challenges aspects of the verdict.Valve Jury Says Rothschild, Atty Broke Anti-Patent Troll Law - Law360Beginning July 1, 2026, new federal limits will cap loans for professional degree students at $50,000 per year and $200,000 total, significantly changing how aspiring lawyers finance law school. Administrators and financial aid experts warn that the cap may push students to rely on private loans, which often carry higher interest rates and fewer protections. Unlike federal loans, private loans are generally not eligible for Public Service Loan Forgiveness, making them riskier for students planning lower-paying public interest careers.Some admitted students are already reconsidering their options, choosing less expensive schools or withdrawing altogether after calculating potential debt burdens. Law schools may need to increase scholarships or other aid to support students who cannot secure private loans. Private lending has been minimal in legal education since 2006, when federal policy allowed graduate students to borrow up to the full cost of attendance, so there is uncertainty about how lenders will respond to renewed demand.Data show that about one-quarter of ABA-accredited law schools currently have average annual federal borrowing above the new $50,000 cap. At some elite institutions, graduates tend to earn high salaries, which may reassure private lenders. However, other schools with high borrowing levels report much lower median earnings, raising concerns about repayment risks. Experts warn that students at lower-ranked schools or from disadvantaged backgrounds could be hit hardest.In response, some schools are creating new financial strategies. The University of Kansas School of Law has launched an in-house loan program with a fixed 5% interest rate for borrowing above the cap. Santa Clara University School of Law is offering guaranteed scholarships to reduce tuition below the federal limit, and applications there have surged. Overall, the loan cap introduces financial uncertainty that could reshape enrollment decisions, access to legal education, and the long-term cost of becoming a lawyer.US law schools, students fear rising costs from new federal loan cap | ReutersThe U.S. Supreme Court has introduced new software designed to help identify potential conflicts of interest involving the justices. The tool will compare information about parties and attorneys in pending cases with financial and other disclosures maintained by each justice's chambers. These automated checks are intended to supplement, not replace, the justices' existing internal review process when deciding whether to step aside from a case.Under current practice, each of the nine justices independently determines whether recusal is necessary. The move comes after the Court adopted its first formal code of conduct in 2023, which states that a justice should withdraw when their impartiality could reasonably be questioned. Critics have pointed out that the code lacks an enforcement mechanism and leaves recusal decisions solely in the hands of the justices themselves.To support the new system, the Court is also strengthening filing requirements. Parties will need to provide more detailed disclosures, including fuller lists of involved entities and relevant stock ticker symbols. These updated requirements will take effect on March 16. Advocacy groups welcomed the technological upgrade as a step toward better ethics oversight, noting that similar conflict-checking systems have long been standard in lower federal courts.US Supreme Court adopts new technology to help identify conflicts of interest | Reuters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Independent journalist Georgia Fort entered a plea of not guilty in federal court to felony charges linked to a January protest inside St. Paul Church. Federal prosecutors allege she was part of a conspiracy under the FACE Act, while Fort maintains she was present strictly to report. Her legal team says it plans to challenge the prosecution's version of events. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Six skiers rescued, nine others still missing after group is caught in Sierra avalanche; Can a Millionaires Tax help fix WA's affordability 'crisis?' Facing doctor shortage, lawmakers in MI explore who can fill the gap; Federal cuts renew push for MA medical debt protections.

Russia's expanding nuclear arsenal, matching U.S. drug prices with Europe's, Federal agencies backing farmers' right to repair, and the fatal takeoff of UPS flight 2976. Plus, Albert Mohler on the borderless illusion, Larry the Cat at Number 10 Downing Street, and the Tuesday morning newsSupport The World and Everything in It today at wng.org/donateAdditional support comes from Pensacola Christian College. Academic excellence, biblical worldview, affordable cost. go.pcci.edu/worldFrom Ridge Haven Camp in North Carolina and Iowa. Summer Camp registration open now at ridgehaven.orgAnd from Dordt University, where the MSN–Family Nurse Practitioner program prepares nurses for Christ-centered, family-focused care. Dordt.edu

One glove. Unknown male DNA. And an investigation that just shifted beneath the surface.Sixteen days after Nancy Guthrie was taken from her Catalina Foothills home, the FBI confirmed that a glove found two miles away contains a DNA profile matching the gloves worn by the suspect in the doorbell footage. That profile is headed to CODIS — but there's no guarantee it returns a name. If the suspect has never been arrested and swabbed, the database returns nothing, and investigators are left with forensic genealogy timelines Nancy may not survive.The evidence handling has been a disaster. Federal sources say Sheriff Nanos blocked the FBI from processing the glove at Quantico. Nanos denies it. The forensic genealogy company Othram called the decision devastating. On Monday, the sheriff's department quietly redirected all evidence questions to the FBI.A CBS 5 reporter says an inside source believes this was a burglary gone wrong. Both agencies denied it. But Robin Dreeke has been reading amateur behavioral markers in the footage on this show for two weeks. Jeff Bennett raised the burglary theory on Day 4 of our coverage. The behavioral evidence was already there.Trump threatened the death penalty Monday. The family has been saying it's never too late to come forward. Those two messages cannot coexist.Helicopters are scanning the desert with signal sniffers trying to detect Nancy's pacemaker. It went silent at 2:28 AM on February 1st and hasn't reconnected. The family has been officially cleared. And the entire case may now ride on whether a glove on a roadside holds enough to identify the person who wore it.#NancyGuthrie #SavannahGuthrie #CODIS #DNAEvidence #SheriffNanos #RobinDreeke #BurglaryTheory #FBIInvestigation #TucsonKidnapping #TrueCrimeJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.

As lawmakers, and people around the country, grapple with what federal immigration enforcement should look like, Janet Napolitano, former DHS Secretary under President Obama, talks about the future - and the past - of ICE.For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org. This episode was produced by Henry Larson and Kai McNamee. It was edited by Sarah Robbins. Our executive producer is Sami Yenigun.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy